Baker Bros. Capital (GP), LLC Insider Trading
Get free email notifications about insider trading for Baker Bros. Capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker Bros. Capital (GP), LLC. Baker Bros. Capital (GP), LLC is a 10% Owner in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and a 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and a Director in INCYTE CORP ($INCY) and a Director in NEUROGEN CORP ($NRGN) and a 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and a 10% Owner in TAPESTRY PHARMACEUTICALS, INC ($NPRO) and a 10% Owner in VIROPHARMA INC ($VPHM) and a Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and a 10% Owner in ADOLOR CORP ($ADLR) and a 10% Owner in ALLOS THERAPEUTICS INC ($ALTH) and a 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and a Director in SEATTLE GENETICS INC /WA ($SGEN) and a Director in GENOMIC HEALTH INC ($GHDX) and a 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL).
Address: 667 MADISON AVENUE 17TH FLOOR NEW YORK US 10021 NY
Companies in which Baker Bros. Capital (GP), LLC is an Insider
ADOLOR CORP
Trading Symbol: ADLRIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Bros. Capital (GP), LLC: 10% Owner
Holdings: 2,902 shares
Latest Transaction: Oct 29 2010
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ALLOS THERAPEUTICS INC
Trading Symbol: ALTHIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Bros. Capital (GP), LLC: 10% Owner
Holdings: 1,629 shares
Latest Transaction: Feb 06 2009
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Ardea Biosciences, Inc./DE
Trading Symbol: IBPIIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Bros. Capital (GP), LLC: 10% Owner
Holdings: 136,010 shares
Latest Transaction: Jan 23 2009
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
AUXILIUM PHARMACEUTICALS INC
Trading Symbol: AUXLIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Bros. Capital (GP), LLC: 10% Owner
Holdings: 6,992 shares
Latest Transaction: Mar 31 2011
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
BIOCRYST PHARMACEUTICALS INC
Trading Symbol: BCRXIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Baker Bros. Capital (GP), LLC: 10% Owner
Holdings: 71,997 shares
Current Value: $408,223
Latest Transaction: Jun 01 2009
$BCRX Market Capitalization: $427.06M
$BCRX Previous Close: $5.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
GENOMIC HEALTH INC
Trading Symbol: GHDXIndustry: SERVICES-MEDICAL LABORATORIES [8071]
Position of Baker Bros. Capital (GP), LLC: Director
Holdings: 194,184 shares
Current Value: $5,338,118
Latest Transaction: Aug 17 2009
$GHDX Market Capitalization: $928.37M
$GHDX Previous Close: $27.49
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
HERON THERAPEUTICS, INC. /DE/
Trading Symbol: HRTXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Bros. Capital (GP), LLC: 10% Owner
Holdings: 0 shares
Latest Transaction: Apr 26 2011
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IDERA PHARMACEUTICALS, INC.
Trading Symbol: IDRAIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Baker Bros. Capital (GP), LLC: 10% Owner
Holdings: 40,077 shares
Current Value: $62,520
Latest Transaction: Jul 30 2008
$IDRA Market Capitalization: $230.34M
$IDRA Previous Close: $1.56
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
INCYTE CORP
Trading Symbol: INCYIndustry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of Baker Bros. Capital (GP), LLC: Director
Holdings: 239,258 shares
Current Value: $28,275,510
Latest Transaction: Sep 23 2010
$INCY Market Capitalization: $23.12B
$INCY Previous Close: $118.18
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NEUROGEN CORP
Trading Symbol: NRGNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Bros. Capital (GP), LLC: Director
Holdings: 690,856 shares
Latest Transaction: Nov 13 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Seagen Inc.
Trading Symbol: SGENIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Baker Bros. Capital (GP), LLC: Director
Holdings: 481,890 shares
Current Value: $29,294,093
Latest Transaction: May 04 2010
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SYNAGEVA BIOPHARMA CORP
Trading Symbol: GEVAIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Baker Bros. Capital (GP), LLC: Director
Holdings: 316,360 shares
Latest Transaction: Feb 02 2007
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
TAPESTRY PHARMACEUTICALS, INC
Trading Symbol: NPROIndustry: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
Position of Baker Bros. Capital (GP), LLC: 10% Owner
Holdings: 0 shares
Latest Transaction: Oct 17 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
VIROPHARMA INC
Trading Symbol: VPHMIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Bros. Capital (GP), LLC: 10% Owner
Holdings: 4,751 shares
Latest Transaction: May 13 2011
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Baker Bros. Capital (GP), LLC
Sentiment: All, ADLR, ALTH, IBPI, AUXL, BCRX, GHDX, HRTX, IDRA, INCY, NRGN, SGEN, GEVA, NPRO, VPHM
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 13 2011 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | J | 0.00 | 101,047 | 0 | 4,751 | 105.8 K to 4.8 K (-95.51 %) |
Apr 26 2011 | HRTX | HERON THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Option Exercise | P | 1,000.00 | 600 | 600,000 | 600 | |
Apr 26 2011 | HRTX | HERON THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Option Exercise | P | 0.04 | 300 | 12 | 300 | |
Mar 31 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 21.98 | 309 | 6,792 | 6,992 | 6.7 K to 7 K (+4.62 %) |
Oct 29 2010 | ADLR | ADOLOR CORP | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 1.18 | 14 | 17 | 2,902 | 2.9 K to 2.9 K (-0.48 %) |
Oct 29 2010 | ADLR | ADOLOR CORP | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 1.19 | 33 | 39 | 2,916 | 2.9 K to 2.9 K (-1.12 %) |
Oct 29 2010 | ADLR | ADOLOR CORP | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 1.30 | 21 | 27 | 2,949 | 3 K to 2.9 K (-0.71 %) |
View all Baker Bros. Capital (GP), LLC insider transactions.